Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

n/

Acetylation of aromatics over acid zeolites: Seeking a viable alternative to Friedel-Crafts catalysts

Abstract Three acid zeolites (H-BEA, H-FAU, and H-MWW) were used as catalysts for acetylation in batch reactors with acetic anhydride of five aromatic compounds (benzenic and naphthalenic derivatives). The substrate reactivity is mainly governed by electronic factors (the nature of the substituents and degree of ring activation), but steric effects also play a relevant role when the reaction takes place in a narrow micropore system. In general, H-FAU was the most active catalyst, whereas with H-BEA remarkable steric constraints were observed. H-MWW showed good stability toward deactivation and an interesting activity of the sites located on the external surface

Processi intensificati in ambito farmaceutico: le applicazioni di potenza delle microonde

L’interesse per le applicazioni di potenza delle microonde, cioè per il riscaldamento attuato mediante campi elettromagnetici, nel settore farmaceutico è relativamente recente e poco diffuso. Un non consolidato knowhow rende prudenti gli investimenti industriali e, sotto un profi lo più tecnico, la necessità di avere una uniforme distribuzione del calore per scongiurare elevate temperature locali nei materiali e la possibilità di un aumento incontrollato di queste costituiscono i principali fattori limitanti. La conoscenza dei meccanismi e dell’intensità delle interazioni campi elettromagnetici-materiali di interesse farmaceutico è alla base del possibile sviluppo di apparecchiature e nuovi metodi di lavorazione

tungsten oxide a catalyst worth studying for the abatement and decontamination of chemical warfare agents

AbstractTungsten(VI) oxide, WO3, was studied and used as a heterogeneous catalyst for the liquid-phase oxidative abatement and solid-phase decontamination of simulants of chemical warfare agents, CWAs. The catalytic performance of WO3 was compared to the one of a soluble W-containing model catalyst, W(IV)-heptaisobutyl polyhedral oligomeric silsesquioxane, W-POSS. In liquid-phase abatement tests, WO3 promoted a complete degradation of the toxic agent simulant within 24 h, in the presence of aqueous hydrogen peroxide, at room temperature. In solid-phase decontamination tests, when WO3 was mixed with sodium perborate as a solid oxidant, it was also tested in the decontamination of a cotton textile support from organosulfide and organophosphonate agents (simulants of blistering and nerve CWAs, respectively), showing promising performances comparable to, or sometimes better than, a nanostructured TiO2 catalyst, taken as a reference material. The environmental impact of the WO3 catalyst was assessed on biolumi..

ACLEESCF. SP. FOVEATUS(COLEOPTERA CURCULIONIDAE), AN EXOTIC PESTOF FICUS CARICAIN ITALY: A SUSTAINABLE APPROACH TO DEFENCE BASEDON ALUMINOSILICATE MINERALS AS HOST PLANT MASKING SOLIDS

The exceptionally frequent entries of alien pest are a major source of concern for the farmers who haveto protect their crops from unknown insects, often without natural enemies in the new areas. A new pestbelonging to the Molytinae family (Coleoptera: Curculionidae), tribe Hylobiini, reported as Acleessp. cf.foveatusVoss, was recently introduced in Italy. The species is responsible for severe damages in many Italianfig nurseries and orchards, particularly in the Italian Central Northern regions, i.e. Tuscany, Ligury andLatium. Currently, no active ingredients are registered against this insect on fig crops. An innovative and eco-friendly approach for controlling this exotic weevil infestation was investigated, by using montmorillonite-based clays, either in their native state or containing copper(II) species, and clinoptilolite zeolites, in order tocheck the perception of the adults’ weevil towards the different solid materials and, subsequently, to evaluatethe capability of these innovative products to act as masking agent with respect to the host plant and/or asrepellent upon contact. The formulations containing copper(II)-exchanged clay and clinoptilolite zeoliteshowed preliminary promising results in terms of efficacy and environmental sustainability

Researchers, trainers and first responders: a synergy for an improved prevention of chemical, biological, radiological and nuclear risks in south-east Asian countries.

Italian scientists active in national research and academic institutions have been collaborating since 2013, under the aegis of the EU Chemical, Biological, Radiological and Nuclear (CBRN) Risk Mitigation Centres of Excellence, with governmental stakeholders and technical partners, in nine countries of South-East Asia, in order to enhance the local capabilities in preventing, monitoring and responding to CBRN incidents due to intentional, accidental or natural causes. The initiatives implied training courses, didactical sessions, live simulations, table-top exercises and interactive train-the-trainer sessions, in the presence of European and local experts, with trans-disciplinary competences covering areas such as chemistry, biology, toxicology, medicine, engineering, law and international right

The still under-investigated role of cognitive deficits in PML diagnosis

Background: Despite cognitive deficits frequently represent the first clinical manifestations of Progressive Multifocal Leukoencephalopathy (PML) in Natalizumab-treated MS patients, the importance of cognitive deficits in PML diagnosis is still under-investigated. The aim of the current study is to investigate the cognitive deficits at PML diagnosis in a group of Italian patients with PML. Methods: Thirty-four PML patients were included in the study. The demographic and clinical data, the lesion load and localization, and the longitudinal clinical course was compared between patients with (n = 13) and without (n = 15) cognitive deficit upon PML suspicion (the remaining six patients were asymptomatic). Clinical presentation of cognitive symptoms was described in detail. Result: After symptoms detection, the time to diagnosis resulted to be shorter for patients presenting with cognitive than for patients with non cognitive onset (p = 0.03). Within patients with cognitive onset, six patients were presenting with language and/or reading difficulties (46.15%); five patients with memory difficulties (38.4%); three patients with apraxia (23.1%); two patients with disorientation (15.3%); two patients with neglect (15.3%); one patients with object agnosia (7.7%), one patient with perseveration (7.7%) and one patient with dementia (7.7%). Frontal lesions were less frequent (p = 0.03), whereas temporal lesions were slightly more frequent (p = 0.06) in patients with cognitive deficits. The longitudinal PML course seemed to be more severe in cognitive than in non cognitive patients (F = 2.73, p = 0.03), but differences disappeared (F = 1.24, p = 0.29) when balancing for the incidence of immune reconstitution syndrome and for other treatments for PML (steroids, plasma exchange (PLEX) and other therapies (Mefloquine, Mirtazapine, Maraviroc). Conclusion: Cognitive deficits at PML onset manifest with symptoms which are absolutely rare in MS. Their appearance in MS patients should strongly suggest PML. Clinicians should be sensitive to the importance of formal neuropsychological evaluation, with particular focus on executive function, which are not easily detected without a formal assessment

Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses

Alongside vaccines, antiviral drugs are becoming an integral part of our response to the SARS-CoV-2 pandemic. Nirmatrelvir-an orally available inhibitor of the 3-chymotrypsin-like cysteine protease-has been shown to reduce the risk of progression to severe COVID-19. However, the impact of nirmatrelvir treatment on the development of SARS-CoV-2-specific adaptive immune responses is unknown. Here, by using mouse models of SARS-CoV-2 infection, we show that nirmatrelvir administration blunts the development of SARS-CoV-2-specific antibody and T cell responses. Accordingly, upon secondary challenge, nirmatrelvir-treated mice recruited significantly fewer memory T and B cells to the infected lungs and mediastinal lymph nodes, respectively. Together, the data highlight a potential negative impact of nirmatrelvir treatment with important implications for clinical management and might help explain the virological and/or symptomatic relapse after treatment completion reported in some individuals